检索结果 - Kerstin Trunzer

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Prospective Molecular Marker Analyses of <i>EGFR</i> and <i>KRAS</i> From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer

    Prospective Molecular Marker Analyses of <i>EGFR</i> and <i>KRAS</i> From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Ca... 由 Wolfram Brugger, Nadja Triller, Maria Błasińska-Morawiec, S. Curescu, Raimundas Sakalauskas, Georgy M. Manikhas, Julien Mazières, Renaud Whittom, Carol Ward, Karen Mayne, Kerstin Trunzer, Federico Cappuzzo

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer

    Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-c... 由 Jennifer Moriatis Wolf, Åslaug Helland, In‐Jae Oh, M.R. Migliorino, Rafał Dziadziuszko, Anna Wrona, Javier de Castro, Julien Mazières, Frank Griesinger, M. Chlistalla, Andrés F. Cardona, Thorsten Ruf, Kerstin Trunzer, Vlatka Smoljanović, Silvia Novello

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

    Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung can... 由 Andrea Ardizzoni, Sérgio Jobim Azevedo, Belén Rubio‐Viqueira, Delvys Rodríguez‐Abreu, Jorge Alatorre-Alexander, Hans J.M. Smit, Jinming Yu, Konstantinos Syrigos, Kerstin Trunzer, Hina Patel, Jonathan Tolson, Andrés F. Cardona, Pablo Diego Perez-Moreno, Tom Newsom‐Davis

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Resistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway Activation

    Resistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway Activation 由 Fei Su, William D. Bradley, Qiongqing Wang, Hong Yang, Lizhong Xu, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, Min Jung Kim, Kerstin Trunzer, Richard J. Lee, Kathleen Schostack, Jade Carter, Thomas Albert, Søren Germer, Jim Rosinski, Mitchell Martin, Mary Ellen Simcox, Brian Lestini, David Heimbrook, Gideon Bollag

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma

    Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma 由 Mario E. Lacouture, Madeleine Duvic, Axel Hauschild, Víctor G. Prieto, Caroline Robert, Dirk Schadendorf, Caroline C. Kim, Christopher McCormack, Patricia L. Myskowski, Olivia Spleiss, Kerstin Trunzer, Fei Su, B. Nelson, K. B. Nolop, Joseph F. Grippo, Richard J. Lee, Matthew J. Klimek, James L. Troy, Andrew K. Joe

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

    Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study 由 Grant A. McArthur, Paul B. Chapman, Caroline Robert, James Larkin, John B.A.G. Haanen, Reinhard Dummer, Antoni Ribas, David Hogg, Omid Hamid, Paolo A. Ascierto, Claus Garbe, Alessandro Testori, Michele Maio, Paul Lorigan, Célèste Lebbé, Thomas Jouary, Dirk Schadendorf, S. O'Day, John M. Kirkwood, Alexander M.M. Eggermont, Brigitte Dréno, Jeffrey A. Sosman, Keith T. Flaherty, Ming Yin, Ivor Caro, Suzanne Cheng, Kerstin Trunzer, Axel Hauschild

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma

    Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma 由 Kerstin Trunzer, Anna C. Pavlick, Lynn M. Schuchter, René González, Grant A. McArthur, Thomas E. Hutson, Stergios J. Moschos, Keith T. Flaherty, Kevin B. Kim, Jeffrey S. Weber, Peter Hersey, Georgina V. Long, Donald P. Lawrence, Patrick A. Ott, Ravi K. Amaravadi, Karl D. Lewis, Igor Puzanov, Roger S. Lo, Astrid Koehler, Mark Kockx, Olivia Spleiss, Annette Schell-Steven, Houston Gilbert, Louise Cockey, Gideon Bollag, Richard J. Lee, Andrew K. Joe, Jeffrey A. Sosman, Antoni Ribas

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    <i>RAS</i>Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

    <i>RAS</i>Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors 由 Fei Su, Amaya Virós, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Olivia Spleiss, Jorge S. Reis‐Filho, Xiangju Kong, Richard C. Koya, Keith T. Flaherty, Paul B. Chapman, Min Jung Kim, Robert Hayward, Matthew J. Martin, Hong Yang, Qiongqing Wang, Holly Hilton, Julie S. Hang, Johannes Noé, Maryou Lambros, Felipe C. Geyer, Nathalie Dhomen, Ion Niculescu‐Duvaz, Alfonso Zambon, Dan Niculescu‐Duvaz, Natasha Preece, Lídia Robert, Nicholas Otte, Stephen Mok, Damien Kee, Yan Ma, Chao Zhang, Gaston Habets, Elizabeth A. Burton, Bernice H. Wong, Hoa Nguyen, Mark Kockx, Luc Andries, Brian Lestini, K. B. Nolop, Richard J. Lee, Andrew K. Joe, James L. Troy, René González, Thomas E. Hutson, Igor Puzanov, Bartosz Chmielowski, Caroline J. Springer, Grant A. McArthur, Jeffrey A. Sosman, Roger S. Lo, Antoni Ribas, Richard Marais

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: